Literature DB >> 27363839

Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein.

Tomoaki Yoh1,2, Tatsushi Kato3, Yoshiaki Hirohata3, Yuya Nakamura3, Hiroyuki Nakayama3, Ryuji Okamura3.   

Abstract

Cholangiolocellular carcinoma (CoCC) is a rare malignant liver tumor derived from hepatic progenitor cells, which exist in the canals of Hering. We encountered a case of CoCC with an extremely poor clinical course, initially showing abnormally elevated serum alfa-fetoprotein (AFP). A 72-year-old male presented with a liver tumor and abnormally elevated serum AFP levels (16,399 ng/ml). We preoperatively diagnosed hepatocellular carcinoma and performed extended right hepatectomy, after which the serum AFP levels remarkably decreased to 97 ng/ml. Postoperatively, the disease was pathologically diagnosed as CoCC. Furthermore, immunohistochemical pathological findings were alcian blue negative, cytokeratin (CK) 7 partially positive, CK19 positive, hepatocyte paraffin-1 negative, membranous negative for epithelial membrane antigen, and AFP negative. Fifty-five days later, intra- and extrahepatic recurrence developed, and the patient died 65 days after surgery. Although CoCCs show favorable outcomes, these characteristics of our case were not previously reported. It is necessary to accumulate more information on CoCC.

Entities:  

Keywords:  AFP; Cholangiolocellular carcioma

Mesh:

Substances:

Year:  2016        PMID: 27363839     DOI: 10.1007/s12328-016-0667-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  8 in total

1.  Cholangiolocellular carcinoma of the liver.

Authors:  P E STEINER; J HIGGINSON
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

2.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.

Authors:  Mina Komuta; Bart Spee; Sara Vander Borght; Rita De Vos; Chris Verslype; Raymond Aerts; Hirohisa Yano; Tetsuya Suzuki; Masanori Matsuda; Hideki Fujii; Valeer J Desmet; Masamichi Kojiro; Tania Roskams
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

3.  A case of a large cholangiolocellular carcinoma.

Authors:  Moe Kadono; Kiminori Kimura; Jun Imamura; Shunichi Saeki; Masanao Kurata; Goro Honda; Koji Tsuruta; Shinichiro Horiguchi; Seishu Hayashi
Journal:  Clin J Gastroenterol       Date:  2011-08-07

4.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

5.  Clinicopathologic study on cholangiolocellular carcinoma.

Authors:  K Shiota; J Taguchi; O Nakashima; M Nakashima; M Kojiro
Journal:  Oncol Rep       Date:  2001 Mar-Apr       Impact factor: 3.906

6.  Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration.

Authors:  M D Dabeva; D A Shafritz
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

7.  A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.

Authors:  K Kozaka; M Sasaki; T Fujii; K Harada; Y Zen; Y Sato; S Sawada; H Minato; O Matsui; Y Nakanuma
Journal:  Histopathology       Date:  2007-06-06       Impact factor: 5.087

8.  Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.

Authors:  Shun-Ichi Ariizumi; Yoshihito Kotera; Satoshi Katagiri; Masayuki Nakano; Yasuni Nakanuma; Akiko Saito; Masakazu Yamamoto
Journal:  Ann Surg Oncol       Date:  2014-03-17       Impact factor: 5.344

  8 in total
  2 in total

1.  Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis.

Authors:  Deyao Shi; Fashuai Wu; Feng Gao; Xiangcheng Qing; Zengwu Shao
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

2.  A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report.

Authors:  Hiroaki Yamane; Tomoyuki Abe; Hironobu Amano; Tsuyoshi Kobayashi; Keiji Hanada; Shuji Yonehara; Hideki Ohdan; Masahiro Nakahara; Toshio Noriyuki
Journal:  Int J Surg Case Rep       Date:  2017-04-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.